KOL Event at ADA 2024: What’s Next in Metabolic Disease Treatment

Jun 24, 2024 from 6:30 AM to 8:30 AM EDT

Webcasted KOL discussion and Q&A session: 7:00 – 8:00 am ET (breakfast served at 6:30 am ET).

Featuring Dr. David A. D’Alessio (Duke University School of Medicine), who will provide insights on the unmet medical need and evolving treatment landscape for patients with obesity and T2D. In addition, members of Fractyl management will discuss the Company’s two novel platforms, Revita® and Rejuva, and their potential to be a single-administration disease-modifying solution.

Fractyl Health KOL Event at ADA - RSVP